Entry |
|
Name |
Regorafenib (USAN/INN); Stivarga (TN) |
Formula |
C21H15ClF4N4O3
|
Exact mass |
482.0769
|
Mol weight |
482.81
|
Structure |

|
Simcomp |
|
Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG02924 UGT substrate
DG03188 UGT1A9 substrate
Transporter substrate
DG01665 ABCB1 substrate
DG01913 ABCG2 substrate
|
Remark |
Product (DG00720): | D10137<JP/US> |
|
Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
Target |
|
Pathway |
|
Metabolism |
Enzyme: CYP3A4 [HSA: 1576], UGT1A9 [HSA: 54600]
Transporter: ABCB1 [HSA: 5243], ABCG2 [HSA: 9429]
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EX Other protein kinase inhibitors
L01EX05 Regorafenib
D10138 Regorafenib (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG00720 Regorafenib
D10138 Regorafenib
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00720 Regorafenib
D10138 Regorafenib
DG02924 UGT substrate
DG03188 UGT1A9 substrate
DG00720 Regorafenib
D10138 Regorafenib
Transporter substrate
DG01665 ABCB1 substrate
DG00720 Regorafenib
D10138 Regorafenib
DG01913 ABCG2 substrate
DG00720 Regorafenib
D10138 Regorafenib
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
TKL group
BRAF
D10138 Regorafenib (USAN/INN)
RAF1
D10138 Regorafenib (USAN/INN)
Receptor tyrosine kinases (RTK)
PDGFR family
PDGFRB
D10138 Regorafenib (USAN/INN)
KIT (CD117)
D10138 Regorafenib (USAN/INN)
FGFR family
FGFR1 (CD331)
D10138 Regorafenib (USAN/INN)
VEGFR family
VEGFR1 (FLT1)
D10138 Regorafenib (USAN/INN)
VEGFR2 (KDR)
D10138 Regorafenib (USAN/INN)
VEGFR3 (FLT4)
D10138 Regorafenib (USAN/INN)
TIE family
TEK (TIE2, CD202)
D10138 Regorafenib (USAN/INN)
RET family
RET
D10138 Regorafenib (USAN/INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10138
Drug transporters
D10138
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG00720 Regorafenib
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00720 Regorafenib
DG02924 UGT substrate
DG03188 UGT1A9 substrate
DG00720 Regorafenib
Transporter substrate
DG01665 ABCB1 substrate
DG00720 Regorafenib
DG01913 ABCG2 substrate
DG00720 Regorafenib
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 C8y C 29.4700 -16.7300
2 C8x C 29.4700 -18.1300
3 C8x C 28.2100 -18.8300
4 C8y C 27.0200 -18.1300
5 C8x C 27.0200 -16.7300
6 C8y C 28.2100 -16.0300
7 X Cl 30.6600 -16.0300
8 N1b N 25.7600 -18.8300
9 C5a C 24.5700 -18.1300
10 N1b N 23.3800 -18.8300
11 O5a O 24.5700 -16.7300
12 C8y C 22.1900 -18.1300
13 C8y C 21.0000 -18.8300
14 C8x C 19.7400 -18.1300
15 C8y C 19.7400 -16.7300
16 C8x C 20.9300 -16.0300
17 C8x C 22.1900 -16.7300
18 O2a O 18.6200 -16.0300
19 C8y C 17.4300 -16.7300
20 C8x C 17.4300 -18.1300
21 C8x C 16.1700 -18.8300
22 N5x N 14.9800 -18.1300
23 C8y C 14.9800 -16.6600
24 C8x C 16.1700 -15.9600
25 C5a C 13.7900 -16.0300
26 N1b N 12.5300 -16.7300
27 O5a O 13.7900 -14.6300
28 C1a C 11.3400 -16.0300
29 X F 21.0000 -20.2300
30 C1d C 28.2100 -14.6300
31 X F 28.2100 -13.2300
32 X F 26.8100 -14.6300
33 X F 29.6100 -14.6300
BOND 35
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 4 8 1
9 8 9 1
10 9 10 1
11 9 11 2
12 10 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 12 17 1
19 15 18 1
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 22 23 1
25 23 24 2
26 19 24 1
27 23 25 1
28 25 26 1
29 25 27 2
30 26 28 1
31 13 29 1
32 6 30 1
33 30 31 1
34 30 32 1
35 30 33 1
|